期刊文献+

内皮素1在肺移植后闭塞性细支气管炎中的效应 被引量:1

Effect of endothelin-1 on obliterative bronchiolitis after lung transplantation
下载PDF
导出
摘要 肺移植后移植物的存活受限于闭塞性细支气管炎的出现。近年来的研究发现,内皮素1在闭塞性细支气管炎的发生发展中起到了一个较为重要的作用,内皮素1具有促炎症反应和促成纤维细胞增殖的作用。而非选择性的内皮素1受体拮抗剂波生坦则能够减弱内皮素的作用,明显减弱气道的闭塞。波生坦主要是通过抑制平滑肌细胞的增殖和明显减少免疫反应性细胞白细胞介素1β和白细胞介素2的数量而起作用的。文章通过相关方面文献的检索,总结了内皮素1在肺移植后闭塞性细支气管炎中的作用,并进一步观察波生坦在治疗闭塞性细支气管炎过程中所发挥作用。 The survival of graft is limited to appearance of obliterative bronchiolitis (OB) after lung transplantation. Recent studies have shown that endothelin-1 exhibits a very important role during the occurrence and development of O8. The endothelin-1 has the effects of promoting inflammation and the proliferation of fibroblasts. Bosentan as a non-selective endotbelin-1 receptor antagonist can reduce the effect of endothelin-t and significantly decrease tracheal occlusion. The bosentan plays its role by suppressing smooth muscle cell proliferation and obviously reducing the number of immunoreactive cells (interleukin-1 β and interleukin-2). Through retrieval of relate references, the article summarizes the effect of endothelin-1 in OB after lung transplantation, and further observes the effect of bosentan on OB treatment.
作者 杨振华 陈昶
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第31期6101-6104,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 上海市科学技术委员会科技基金资助(044109)~~
  • 相关文献

参考文献28

  • 1Hertz Ml,Mohacsi PJ,Boucek MM,et al.The Registry of the International Society for Heart and Lung Transplantation:past,present and future.J Heart Lung Transplant.2002;21(9):945-949.
  • 2Trulock EP,Christie JD,Edwards LB,et al.Registry of the International Society for Heart and Lung Transplantation:twenty-fourth official adult lung and heart-lung transplantation report-2007.J Heart Lung Transplant.2007;26(8):782-795.
  • 3Laohaburanakit P,Chan A,Allen RP.Bronchiolitis obliterans.Clin Rev Allergy Immunol.2003;25(3):259-274.
  • 4Ooi GC,Peh WC,lp M.High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation.Respiration.1998;65(3):187-191.
  • 5Jackson CH,Sharpies LD,McNeil K,et al.Acute and chronic onset of bronchiolitis obliterans syndrome(BOS):are they different entities? J Heart Lung Transplant.2002;21(6):658-666.
  • 6Lama VN,Murray S,Lonigro RJ,et al.Course of FEV(1)after onset of bronchiolitis obliterans syndrome in lung transplant recipients.Am J Respir Crit Care Med.2007;175(11):1192-1198.
  • 7Reichenspurner H,Girgis RE,Robbins RC,et al.Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.Ann Thorac Surg.1996;62(5):1467-1472;discussion 1472-1473.
  • 8Boehler A,Estenne M.Obliterative bronchiolitis after lung transplantation.Curr Opin Pulm Med.2000;6(2):133-139.
  • 9Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature.1988;332(6163):411-415.
  • 10Iwamuro Y,Miwa S,Zhang XF,et al.Activation of three types of voltage-independent Ca2+ channel in A7r5 cells by endothelin-1 as revealed by a novel Ca2+ channel blocker LOE 908.Br J Pharmacol.1999;126(5):1107-1114.

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部